中基長壽科學(00767.HK)訂立合作開發市場合約
中基長壽科學(00767.HK)公布,附屬浤烽與中華麥飯石生命科技訂立合作開發市場合約。合約期限為2022年7月4日至2025年7月4日。
中華麥飯石生命科技向浤烽分期提供不少於3,000萬元合作營運資金款,首期金額不少於1,000萬元,中華麥飯石應於合約簽署生效的7個工作日內支付合同協定費用;中華麥飯石生命科技有權使用浤烽的場地,包括辦公室、實驗室設備及人員;雙方共同組建及營運聯合直銷團隊,以促進生物制品與基因檢測、細胞檢測等服務的銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.